BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22182184)

  • 1. Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type XVII collagen.
    Hayashi I; Shinkuma S; Shimizu S; Natsuga K; Ujiie H; Yasui C; Tsuchiya K; Nishie W; Shimizu H
    Br J Dermatol; 2012 May; 166(5):1116-20. PubMed ID: 22182184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating IgA and IgE autoantibodies in antilaminin-332 mucous membrane pemphigoid.
    Natsuga K; Nishie W; Shinkuma S; Moriuchi R; Shibata M; Nishimura M; Hashimoto T; Shimizu H
    Br J Dermatol; 2010 Mar; 162(3):513-7. PubMed ID: 19751242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180.
    Choi Y; Lee SE; Fukuda S; Hashimoto T; Kim SC
    J Dermatol; 2011 Feb; 38(2):169-72. PubMed ID: 21269314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
    Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
    Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model.
    Ujiie H; Shibaki A; Nishie W; Shinkuma S; Moriuchi R; Qiao H; Shimizu H
    Clin Immunol; 2012 Feb; 142(2):167-75. PubMed ID: 22044750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Anti-BP180-type Mucous Membrane Pemphigoid with IgG and IgA Autoantibodies Showing Distinct Reactivities.
    Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Nakazawa M; Sawamura D
    Acta Dermatovenerol Croat; 2022 Jul; 30(1):54-56. PubMed ID: 36153720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180.
    Schmidt E; Skrobek C; Kromminga A; Hashimoto T; Messer G; Bröcker EB; Yancey KB; Zillikens D
    Br J Dermatol; 2001 Nov; 145(5):778-83. PubMed ID: 11736901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
    Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
    J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner.
    Natsuga K; Nishie W; Shinkuma S; Ujiie H; Nishimura M; Sawamura D; Shimizu H
    J Immunol; 2012 Jun; 188(11):5792-9. PubMed ID: 22523387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laminin-5 is targeted by autoantibodies in feline mucous membrane (cicatricial) pemphigoid.
    Olivry T; Dunston SM; Zhang G; Ghohestani RF
    Vet Immunol Immunopathol; 2002 Sep; 88(3-4):123-9. PubMed ID: 12127411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-collagen XVII single-chain Fv antibody blocks the autoimmune reaction mediated by pathogenic autoantibodies in bullous pemphigoid.
    Wu Y; Sun NN; Dang EL; Jin L; Liu ZF; Zhang W; Yang LT; Wang G
    J Dermatol Sci; 2013 Oct; 72(1):25-31. PubMed ID: 23827201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
    Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute blistering disease presenting IgG autoantibodies against NC16A and COOH-terminal domains of BP180 and laminin-332, with characteristic distribution of eruptions.
    Kurashige Y; Minemura T; Nagatani T; Koga H; Hashimoto T
    Eur J Dermatol; 2013; 23(1):109-10. PubMed ID: 23306276
    [No Abstract]   [Full Text] [Related]  

  • 14. A spontaneous canine model of mucous membrane (cicatricial) pemphigoid, an autoimmune blistering disease affecting mucosae and mucocutaneous junctions.
    Olivry T; Dunston SM; Schachter M; Xu L; Nguyen N; Marinkovich MP; Chan LS
    J Autoimmun; 2001 Jun; 16(4):411-21. PubMed ID: 11437489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized linear IgA/IgG bullous dermatosis.
    Shimizu S; Natsuga K; Shinkuma S; Yasui C; Tsuchiya K; Shimizu H
    Acta Derm Venereol; 2010 Nov; 90(6):621-4. PubMed ID: 21057747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of original B cells producing pathogenic IgG and IgA autoantibodies in anti-BP180-type mucous membrane pemphigoid.
    Hayashi D; Hashimoto T; Mine M; Ishii N; Hashimoto K; Tsuchisaka A; Tsuruta D
    Arch Dermatol Res; 2024 May; 316(5):169. PubMed ID: 38734797
    [No Abstract]   [Full Text] [Related]  

  • 17. Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.
    Ujiie H; Sasaoka T; Izumi K; Nishie W; Shinkuma S; Natsuga K; Nakamura H; Shibaki A; Shimizu H
    J Immunol; 2014 Nov; 193(9):4415-28. PubMed ID: 25261486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subepidermal blistering disease with autoantibodies to both the p200 autoantigen and the alpha3 chain of laminin 5.
    Shimanovich I; Petersen EE; Weyers W; Sitaru C; Zillikens D
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S90-2. PubMed ID: 15858518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of childhood bullous pemphigoid.
    Toyama T; Nakamura K; Kuramochi A; Ohyama B; Hashimoto T; Tsuchida T
    Eur J Dermatol; 2009; 19(4):368-71. PubMed ID: 19451055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgE autoantibodies against the intracellular domain of BP180.
    Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
    Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.